停用醋酸环丙孕酮后脑膜瘤病的不典型演变:临床病例与组织分子特征
该研究报告4例长期使用醋酸环丙孕酮(CPA)后出现多发脑膜瘤的女性患者,停用CPA后肿瘤体积呈现相反演变(部分继续生长、部分缩小)。对继续生长的肿瘤行手术及组织学和基因分析,发现生长肿瘤多为纤维型、脑膜皮型或过渡型,并检出NF2突变;缩小的颅底肿瘤检出PIK3CA突变且纤维化明显。
要点
- 停用CPA后多数脑膜瘤稳定或缩小,但部分仍可继续生长。
- 同一患者不同部位脑膜瘤可呈相反体积演变。
- 生长肿瘤以纤维型、脑膜皮型或过渡型为主,可伴NF2突变。
核心结论
- 停用CPA后脑膜瘤可呈现不典型演变,即同一患者不同肿瘤体积变化相反。
- 肿瘤演变差异可能与组织学亚型、基因突变谱及脑膜胚胎起源有关,需进一步研究。
研究设计与样本
- 回顾性病例系列,纳入停用CPA后出现相反肿瘤演变的多发脑膜瘤患者。
- 对生长肿瘤行手术,并进行组织学和基因分析;对肿瘤进行回顾性体积分析。
主要发现
- 共识别4例女性患者,均为多发脑膜瘤且停用CPA后肿瘤体积演变相反。
- 继续生长的凸面及天幕肿瘤为纤维型脑膜瘤;缩小的颅底肿瘤为纤维型伴广泛纤维化和胶原形成。
- 两个生长的颅底肿瘤分别为脑膜皮型和过渡型;生长的肿瘤中检出2个NF2突变,缩小的颅底肿瘤检出PIK3CA突变。
临床怎么用
- 停用CPA后仍需影像随访,警惕部分脑膜瘤继续生长。
- 对继续生长的肿瘤应考虑手术并完善组织分子分析。
局限性
- 样本量小(4例),结论需更大样本验证。
- 生物学机制及突变谱与脑膜胚胎起源的关系尚不明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The long-term use of cyproterone acetate (CPA) is associated with an increased risk of developing intracranial meningiomas. CPA discontinuation most often induces a stabilization or regression of the tumor. The underlying biological mechanisms as well as the reasons why some meningiomas still grow after CPA discontinuation remain unknown. We reported a series of patients presenting CPA-induced meningiomatosis with opposed tumor evolutions following CPA discontinuation, highlighting the underlying histological and genetic features. METHODS: Patients presenting several meningiomas with opposite tumor evolution (coexistence of growing and shrinking tumors) following CPA discontinuation were identified. Clinical and radiological data were reviewed. A retrospective volumetric analysis of the meningiomas was performed. All the growing meningiomas were operated. Each operated tumor was characterized by histological and genetic analyses. RESULTS: Four women with multiple meningiomas and opposite tumor volume evolutions after CPA discontinuation were identified. Histopathological analysis characterized the convexity and tentorial tumors which continued to grow after CPA discontinuation as fibroblastic meningiomas. The decreasing skull base tumor was characterized as a fibroblastic meningioma with increased fibrosis and a widespread collagen formation. The two growing skull base meningiomas were identified as meningothelial and transitional meningiomas. The molecular characterization found two NF2 mutations among the growing meningiomas and a PIK3CA mutation in the skull base tumor which decreased. CONCLUSION: To our knowledge, this is the first report describing an atypical tumor evolution of CPA-associated meningiomas after CPA discontinuation. The underlying biological mechanisms explaining this observation and especially the close relationship between mutational landscapes and embryologic origins of the meninges in CPA-related meningiomas as well as their clonal origin require further research.
引用
- Passeri T, Giammattei L, Le Van T, et al. Atypical evolution of meningiomatosis after discontinuation of cyproterone acetate: clinical cases and histomolecular characterization. Acta Neurochir (Wien). 2021. PMID: 34613529. doi:10.1007/s00701-021-05005-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。